GALT icon

Galectin Therapeutics

62 hedge funds and large institutions have $13M invested in Galectin Therapeutics in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 8 closing their positions.

Holders
62
Holders Change
-1
Holders Change %
-1.59%
% of All Funds
1.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
22
Reduced
16
Closed
8
Calls
$15K
Puts
$679K
Net Calls
-$664K
Net Calls Change
+$164K
Name Market Value Shares Shares
Change
Shares
Change %
Citigroup
51
Citigroup
New York
$11K 3,232 +1,284 +66%
AllianceBernstein
52
AllianceBernstein
Tennessee
$8K 2,200 -1,800 -45%
First Manhattan
53
First Manhattan
New York
$5K 1,667
OIA
54
Optimum Investment Advisors
Illinois
$4K 1,126 +500 +80%
Barclays
55
Barclays
United Kingdom
$4K 1,411 +1,224 +655%
LTFS
56
Ladenburg Thalmann Financial Services
Florida
$3K 827 +119 +17%
PSI
57
Pinnacle Summer Investments
Virginia
$1K 167
TWA
58
TCI Wealth Advisors
Arizona
$1K 300
SM
59
Sabby Management
Florida
$55 15,842 +15,842 New
Manulife (Manufacturers Life Insurance)
60
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 157 -9,089 -98%
CCA
61
Catalyst Capital Advisors
New York
-675,000 Closed
Macquarie Group
62
Macquarie Group
Australia
-20,000 Closed
CL
63
Choreo LLC
Illinois
-10,020 Closed
AA
64
Apriem Advisors
California
-1,600 Closed
RIA
65
Regal Investment Advisors
Michigan
-1,500 Closed
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
-897 Closed
IPC
67
Independent Portfolio Consultants
Florida
-570 Closed
AAM
68
American Asset Management
Florida
-84 Closed
SO
69
STRS Ohio
Ohio
Royal Bank of Canada
70
Royal Bank of Canada
Ontario, Canada
$0 100
Bank of Montreal
71
Bank of Montreal
Ontario, Canada
$0 100 +100 New